AIWall Street Journal1h ago
A look at OpenAI-backed Red Queen Bio, an AI biosecurity startup
A look at OpenAI-backed Red Queen Bio, an AI biosecurity startup with $36M raised to design antibody drugs against pathogens, including AI-enabled bioweapons
TL;DRAI startup funded by OpenAI is building antibodies against threats from future AI-designed bioweapons.
Why it matters: Addresses potential dual-use AI risk by preparing defenses before malicious actors weaponize biology.
Red Queen Bio is using artificial intelligence to design antibody drugs for novel pathogens—before future AI systems create them
Read full articleSource: Wall Street Journal · Opens in new tab